Marlio Charles Mosseri, 10% Owner at Nuvectis Pharma, Inc. (NVCT), bought 47,329 shares at $8.90 ($423K) on 2025-05-09, disclosed to the SEC on 2025-05-12.
Open-market purchase of $423k NVCT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.71 | 100 | $871 | 0.2% |
| 2 | $8.97 | 2,400 | $22K | 5.1% |
| 3 | $8.99 | 100 | $899 | 0.2% |
| 4 | $8.90 | 9,817 | $87K | 20.7% |
| 5 | $8.90 | 9,817 | $87K | 20.7% |
| 6 | $8.95 | 9,850 |
| $88K |
| 20.9% |
| 7 | $8.95 | 9,850 | $88K | 20.9% |
| 8 | $8.98 | 5,395 | $48K | 11.5% |
| Total | $8.93 avg | 47,329 | $423K | 100% |
| Filing → |
| NVCT | BUY | 2025-06-24 | $45K | — | Filing → |
| NVCT | BUY | 2025-06-20 | $495K | — | Filing → |
| NVCT | BUY | 2025-05-13 | $343K | — | Filing → |